Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study
Main Authors: | François, Karlien, Wissing, Karl Martin, Jacobs, Rita, Boone, Dries, Jacobs, Kristine, Tielemans, Christian |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088363/ |
Similar Items
-
The effect of citrate dialysate on intradialytic heparin dose in haemodialysis patients: study design of a randomised controlled trial
by: Tai, Davina J., et al.
Published: (2015) -
Is Anticoagulation Discontinuation Achievable with Citrate Dialysate during HDF Sessions?
by: Dolley-Hitze, Thibault, et al.
Published: (2016) -
Citrate anticoagulation realized as CVVHD using a newly designed dialysate solution
by: Morgera, S, et al.
Published: (2006) -
Low-molecular weight heparin infusion as anticoagulation for haemodialysis
by: Wong, Steve Siu-Man, et al.
Published: (2016) -
Citrate Anticoagulation for CRRT in Children: Comparison with Heparin
by: Fernández, Sara Nicole, et al.
Published: (2014)